Phathom Pharmaceuticals
PHAT
PHAT
82 hedge funds and large institutions have $349M invested in Phathom Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 83 → 82 (-1)
10.04% less ownership
Funds ownership: 90.94% → 80.91% (-10%)
38% less capital invested
Capital invested by funds: $562M → $349M (-$213M)
Holders
82
Holding in Top 10
4
Calls
$1.29M
Puts
$1K
Top Buyers
| 1 | +$3.15M | |
| 2 | +$2.63M | |
| 3 | +$2.18M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.31M |
| 5 |
PMAM
Penn Mutual Asset Management
Conshohocken,
Pennsylvania
|
+$1.18M |
Top Sellers
| 1 | -$115M | |
| 2 | -$61.3M | |
| 3 | -$3.93M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.26M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$2.87M |